Domen R E
Department of Clinical Pathology, Cleveland Ohio Clinic Foundation 44195, USA.
Arch Pathol Lab Med. 1995 Sep;119(9):807-10.
The Food and Drug Administration currently requires written authorization from the patient's physician before autologous units of blood that are positive or reactive for hepatitis B surface antigen or anti-human immunodeficiency virus can be shipped from a site of collection different from the site of transfusion. Additionally, the Blood Products Advisory Committee has recommended the universal testing of all autologous units of blood.
The case of an autologous blood donor with positive infectious disease markers is presented. The ethics of infectious disease testing of patients who preoperatively donate their own blood is discussed.
Many ethical issues are raised by policies requiring infectious disease testing of the autologous blood donor. Blood banking and transfusion medicine specialists should examine the ethical issues raised by regulatory mandates to perform infectious disease testing of the patient who desires to make a preoperative autologous blood donation.
A policy that protects the rights of the patient as well as the rights and concerns of health care professionals should be pursued.
美国食品药品监督管理局目前要求，若自体血液单位的乙型肝炎表面抗原或抗人类免疫缺陷病毒检测呈阳性或反应性，则在将其从不同于输血地点的采集地点运送之前，需获得患者医生的书面授权。此外，血液制品咨询委员会已建议对所有自体血液单位进行普遍检测。
介绍了一名自体血液捐献者传染病标志物呈阳性的病例。讨论了对术前捐献自身血液的患者进行传染病检测的伦理问题。
要求对自体血液捐献者进行传染病检测的政策引发了许多伦理问题。血库和输血医学专家应审视监管要求对希望进行术前自体血液捐献的患者进行传染病检测所引发的伦理问题。
应推行一项既能保护患者权利，又能兼顾医护人员权利和关切的政策。
